Expression of Survivin Does Not Appear to Influence Breast Cancer Recurrence Risk

BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells. METHODS: We estimated the association between nuclear and cytoplasmic survivin expression in primary t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta Oncol
Hlavní autoři: Collin, Lindsay J, Cronin-Fenton, Deirdre P, Ahern, Thomas P, Christensen, Kristina B, Damkier, Per, Hamilton-Dutoit, Stephen, Kjærsgaard, Anders, Lauridsen, Kristina L, Yacoub, Rami, Christiansen, Peer, Sørensen, Henrik Toft, Lash, Timothy L
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386593/
https://ncbi.nlm.nih.gov/pubmed/30351173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2018.1503419
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky